Tatva Chintan Pharma Chem

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

11 Nov, 2025 | 11:07am • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

07 Nov, 2025 | 12:02pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

06 Nov, 2025 | 04:34pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

05 Nov, 2025 | 02:00pm • Source: BSE

Transcript of the earnings call held on 31 October 2025 post announcement of the financial results of the Company for the quarter and half year...

04 Nov, 2025 | 12:16pm • Source: BSE

Newspaper Publication of Extract of Financial Results of the Company for the quarter and half year ended 30 September 2025.

01 Nov, 2025 | 11:38am • Source: BSE

Link of Audio Recording of the Earnings call held on Friday, 31 October 2025 at 05:00 p.m. (IST) is attached.

31 Oct, 2025 | 07:18pm • Source: BSE

Investor Presentation for the quarter and half year ended 30 September 2025.

31 Oct, 2025 | 04:06pm • Source: BSE

Detailed disclosure is enclosed.

31 Oct, 2025 | 03:55pm • Source: BSE

Detailed disclosure is enclosed.

31 Oct, 2025 | 03:52pm • Source: BSE

Outcome Of the Board Meeting Held On 31.10.2025

31 Oct, 2025 | 03:49pm • Source: BSE

Enclosed

31 Oct, 2025 | 03:45pm • Source: BSE

Clarification on Price Movement

24 Oct, 2025 | 10:53am • Source: BSE

Significant movement in price has been observed in Tatva Chintan Pharma Chem Limited. The Exchange, in order to ensure that investors have latest relevant information...

24 Oct, 2025 | 10:52am • Source: NSE

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call...

17 Oct, 2025 | 08:51pm • Source: BSE

Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to...

17 Oct, 2025 | 08:31pm • Source: BSE

Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

06 Oct, 2025 | 05:18pm • Source: BSE

Summary of proceedings of the 29th Annual General Meeting held on Friday, 26 September 2025.

26 Sep, 2025 | 07:14pm • Source: BSE

Intimation of Closure of Trading Window

25 Sep, 2025 | 05:38pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

04 Sep, 2025 | 07:27pm • Source: BSE